These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1472103)

  • 21. 1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats.
    Napoli C; Salomone S; Godfraind T; Palinski W; Capuzzi DM; Palumbo G; D'Armiento FP; Donzelli R; de Nigris F; Capizzi RL; Mancini M; Gonnella JS; Bianchi A
    Stroke; 1999 Sep; 30(9):1907-15. PubMed ID: 10471444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of efonidipine hydrochloride (NZ-105) on modification of low density lipoprotein induced by rat cultured endothelial cells].
    Ito S; Higashino R; Tanaka T; Takei M; Kurimoto T; Matsuda K
    Nihon Yakurigaku Zasshi; 1995 Oct; 106(4):263-70. PubMed ID: 8537073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison among the effects of nifedipine, nimodipine and nisoldipine on the brain biogenic amines of normal or haloperidol treated rats.
    Gaggi R; Cont R; Gianni AM
    Gen Pharmacol; 1993 Sep; 24(5):1091-6. PubMed ID: 8270166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypotensive effects of dihydropyridine derivatives.
    Kamei C; Kurokawa K; Tasaka K
    Arzneimittelforschung; 1985; 35(9):1377-80. PubMed ID: 2935160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of some 1,4-dihydropyridine Ca antagonists on the blast transformation of rat spleen lymphocytes.
    Briede J; Daija D; Bisenieks E; Makarova N; Uldriķis J; Poikans J; Duburs G
    Cell Biochem Funct; 1999 Jun; 17(2):97-105. PubMed ID: 10377955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines.
    Nègre-Salvayre A; Salvayre R
    Free Radic Biol Med; 1992; 12(2):101-6. PubMed ID: 1559614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of transient outward K+ current by DHP Ca2+ antagonists and agonists in rabbit cardiac myocytes.
    Gotoh Y; Imaizumi Y; Watanabe M; Shibata EF; Clark RB; Giles WR
    Am J Physiol; 1991 May; 260(5 Pt 2):H1737-42. PubMed ID: 1709794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of L-type calcium channel blockade by lacidipine in guinea-pig ventricular myocytes.
    Cerbai E; Giotti A; Mugelli A
    Br J Pharmacol; 1997 Feb; 120(4):667-75. PubMed ID: 9051306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol.
    Lupo E; Locher R; Weisser B; Vetter W
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1803-8. PubMed ID: 7945331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticonvulsant effects of dihydropyridine Ca2+ antagonists in electrocortical shock seizures.
    Meyer FB; Anderson RE; Sundt TM
    Epilepsia; 1990; 31(1):68-74. PubMed ID: 2137409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of dihydropyridines and inorganic calcium blockers on aggregation and on intracellular free calcium in platelets.
    Palés J; Palacios-Araus L; López A; Gual A
    Biochim Biophys Acta; 1991 May; 1064(2):169-74. PubMed ID: 1645196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A number of marketed dihydropyridine calcium channel blockers have mineralocorticoid receptor antagonist activity.
    Dietz JD; Du S; Bolten CW; Payne MA; Xia C; Blinn JR; Funder JW; Hu X
    Hypertension; 2008 Mar; 51(3):742-8. PubMed ID: 18250364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic effects of a dihydropyridine calcium antagonist, NB-818 (NPK-1886) in anesthetized dogs.
    Nishikibe M; Nagura J; Kamei K; Fukuroda T
    Arch Int Pharmacodyn Ther; 1988; 291():7-20. PubMed ID: 3365068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages.
    Szabó C; Thiemermann C; Vane JR
    Biochem Biophys Res Commun; 1993 Oct; 196(2):825-30. PubMed ID: 7694580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of calcium antagonists on the erythrocyte membrane.
    Abe H; Katada K; Orita M; Nishikibe M
    J Pharm Pharmacol; 1991 Jan; 43(1):22-6. PubMed ID: 1676054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated analysis on the physicochemical properties of dihydropyridine calcium channel blockers in grapefruit juice interactions.
    Uesawa Y; Takeuchi T; Mohri K
    Curr Pharm Biotechnol; 2012 Jul; 13(9):1705-17. PubMed ID: 22039822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human equilibrative nucleoside transporters by dihydropyridine-type calcium channel antagonists.
    Li RW; Tse CM; Man RY; Vanhoutte PM; Leung GP
    Eur J Pharmacol; 2007 Jul; 568(1-3):75-82. PubMed ID: 17512522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of polyvalent cations and dihydropyridine calcium channel blockers on recovery of CNS white matter from anoxia.
    Stys PK; Ransom BR; Waxman SG
    Neurosci Lett; 1990 Jul; 115(2-3):293-9. PubMed ID: 2234507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of benidipine on depolarizing stimulation-induced increase of intracellular calcium concentration in cultured mouse hippocampal neurons.
    Tsukuda E; Matsuda Y
    Jpn J Pharmacol; 1999 Dec; 81(4):401-3. PubMed ID: 10669048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dihydropyridine Ca2+ antagonists: potent inhibitors of secretion from normal and transformed pituitary cells.
    Enyeart JJ; Aizawa T; Hinkle PM
    Am J Physiol; 1985 May; 248(5 Pt 1):C510-9. PubMed ID: 3922229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.